Literature DB >> 21422235

MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer.

Philipp Hofer1, Andreas Baierl, Elisabeth Feik, Gerhard Führlinger, Gernot Leeb, Karl Mach, Klaus Holzmann, Michael Micksche, Andrea Gsur.   

Abstract

Telomerase reactivation and expression of human telomerase gene [human telomerase reverse transcriptase (hTERT)] are hallmarks of unlimited proliferation potential of cancer cells. A polymorphic tandem repeats minisatellite of hTERT gene, termed MNS16A was reported to influence hTERT expression. To assess the role of MNS16A as potential biomarker for colorectal cancer (CRC), we investigated for the first time the association of MNS16A genotypes with risk of colorectal polyps and CRC. In the ongoing colorectal cancer study of Austria (CORSA), 3842 Caucasian participants were recruited within a large screening project in the province Burgenland including 90 CRC cases, 308 high-risk polyps, 1022 low-risk polyps and 1822 polyp free controls verified by colonoscopy. MNS16A genotypes were determined by polymerase chain reaction from genomic DNA. Associations of MNS16A genotypes with CRC risk were estimated by logistic regression analysis computing odds ratios (ORs) and 95% confidence intervals (CIs). We identified five different variable number of tandem repeats (VNTRs) of MNS16A including VNTR-364, a newly discovered rare variant. VNTR-274 allele was associated with a 2.7-fold significantly increased risk of CRC compared with the VNTR-302 wild-type (OR = 2.69; 95% CI = 1.11-6.50; P = 0.028). In our CORSA study, the medium length VNTR-274 was identified as risk factor for CRC. Although, this population-based study herewith reports the largest cohort size concerning MNS16A thus far, further large-scale studies in diverse populations are warranted to confirm hTERT MNS16A genotype as potential biomarker for assessment of CRC risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422235      PMCID: PMC3314280          DOI: 10.1093/carcin/bgr053

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  24 in total

Review 1.  A survey of telomerase activity in human cancer.

Authors:  J W Shay; S Bacchetti
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

2.  Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  Telomere reduction in human colorectal carcinoma and with ageing.

Authors:  N D Hastie; M Dempster; M G Dunlop; A M Thompson; D K Green; R C Allshire
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

Review 4.  The molecular structure of centromeres and telomeres.

Authors:  E H Blackburn
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

5.  High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.

Authors:  N Tatsumoto; E Hiyama; Y Murakami; Y Imamura; J W Shay; Y Matsuura; T Yokoyama
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

6.  Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer.

Authors:  Guang Jin; Seung Soo Yoo; Sukki Cho; Hyo-Sung Jeon; Won-Kee Lee; Hyo-Gyoung Kang; Yi Young Choi; Jin Eun Choi; Sung-Ick Cha; Eung Bae Lee; Chang Ho Kim; Tae Hoon Jung; Young Tae Kim; Jae Yong Park
Journal:  Cancer Sci       Date:  2010-11-18       Impact factor: 6.716

7.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

8.  Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer.

Authors:  Luo Wang; Jean-Charles Soria; Yoon-Soo Chang; Ho-Young Lee; Qingyi Wei; Li Mao
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

9.  Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.

Authors:  Ralf Gertler; Robert Rosenberg; Dominik Stricker; Jan Friederichs; Axel Hoos; Martin Werner; Kurt Ulm; Bernhard Holzmann; Hjalmar Nekarda; Joerg-Ruediger Siewert
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

10.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

View more
  19 in total

1.  Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.

Authors:  Andrew J Pellatt; Roger K Wolff; Gabriela Torres-Mejia; Esther M John; Jennifer S Herrick; Abbie Lundgreen; Kathy B Baumgartner; Anna R Giuliano; Lisa M Hines; Laura Fejerman; Richard Cawthon; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2013-04-30       Impact factor: 5.006

2.  Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.

Authors:  Andrew J Pellatt; Roger K Wolff; Abbie Lundgreen; Richard Cawthon; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

Review 3.  Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.

Authors:  Simone Mocellin; Daunia Verdi; Karen A Pooley; Maria T Landi; Kathleen M Egan; Duncan M Baird; Jennifer Prescott; Immaculata De Vivo; Donato Nitti
Journal:  J Natl Cancer Inst       Date:  2012-04-20       Impact factor: 13.506

Review 4.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

5.  HTERT MNS16A polymorphism in breast cancer: a case-control study.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Maria Gazouli; Alexandra Tsigginou; Constantine Dimitrakakis; Evaggelos Eleutherakis-Papaiakovou; Irene Papaspyrou; Dimosthenis Chrysikos; George Theodoropoulos; George C Zografos; Aris Antsaklis; Athanassios-Meletios Dimopoulos; Christos A Papadimitriou
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

Review 6.  Telomerase at the intersection of cancer and aging.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Trends Genet       Date:  2013-07-19       Impact factor: 11.639

7.  Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.

Authors:  Fernando Bellido; Elisabet Guinó; Shantie Jagmohan-Changur; Nuria Seguí; Marta Pineda; Matilde Navarro; Conxi Lázaro; Ignacio Blanco; Hans F A Vasen; Victor Moreno; Gabriel Capellá; Juul T Wijnen; Laura Valle
Journal:  Eur J Hum Genet       Date:  2012-09-05       Impact factor: 4.246

8.  The MNS16A VNTR polymorphism of the TERT gene in bladder cancer.

Authors:  Songül Budak Diler; Fikriye Polat; Günsel Bingöl
Journal:  Turk J Urol       Date:  2019-11-29

9.  Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis.

Authors:  Christine Heinzle; Andrea Gsur; Monika Hunjadi; Zeynep Erdem; Christine Gauglhofer; Stefan Stättner; Josef Karner; Martin Klimpfinger; Friedrich Wrba; Andrea Reti; Balazs Hegedus; Andreas Baierl; Bettina Grasl-Kraupp; Klaus Holzmann; Michael Grusch; Walter Berger; Brigitte Marian
Journal:  Cancer Res       Date:  2012-09-12       Impact factor: 12.701

10.  Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies.

Authors:  Nikos Papadimitriou; Marc J Gunter; Neil Murphy; Audrey Gicquiau; David Achaintre; Stefanie Brezina; Tanja Gumpenberger; Andreas Baierl; Jennifer Ose; Anne J M R Geijsen; Eline H van Roekel; Andrea Gsur; Biljana Gigic; Nina Habermann; Cornelia M Ulrich; Ellen Kampman; Matty P Weijenberg; Per Magne Ueland; Rudolf Kaaks; Verena Katzke; Vittorio Krogh; Bas Bueno-de-Mesquita; Eva Ardanaz; Ruth C Travis; Matthias B Schulze; Maria-José Sánchez; Sandra M Colorado-Yohar; Elisabete Weiderpass; Augustin Scalbert; Pekka Keski-Rahkonen
Journal:  Int J Cancer       Date:  2021-07-12       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.